Who owns the OTINOVA trademark?

The OTINOVA trademark is owned by Circius Pharma AB.

What class is the OTINOVA trademark registered in?

The OTINOVA trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for OTINOVA?

The USPTO serial number for OTINOVA is 79343657.

What is the registration number for OTINOVA?

OTINOVA is registered under USPTO registration number 7102526.

Sealvo

Home Search: OTINOVAOTINOVA #79343657

Back

Updated Oct 5, 2026·40 searches this week

View on USPTO TSDR Find similar marks

OTI

USPTO Trademark Record

REGISTERED

OTINOVA

SN 79343657·Reg 7102526·Filed Feb 02, 2022

Owner Circius Pharma AB

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

OTINOVA (Serial No. 79343657), Registration No. 7102526, is a registered US trademark filed on Feb 02, 2022 by Circius Pharma AB. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: July 11, 2029

Mark Intelligence

OTINOVA (Reg. #7102526) is a registered US trademark that has been protecting its owner, Circius Pharma AB, since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Feb 02, 2022

SERIAL

79343657

REG#

7102526

REGISTERED

Jul 11, 2023

Filing Information

StatusREGISTERED

Filing DateFeb 02, 2022

Serial Number79343657

Registration No.7102526

Registration DateJul 11, 2023

Status DateJul 11, 2023

Published for OppositionApr 25, 2023

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

26 events

FINAL DECISION TRANSACTION PROCESSED BY IB

Nov 06, 2023

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Oct 13, 2023

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Oct 13, 2023

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Oct 11, 2023

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Jul 11, 2023

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 11, 2023

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Apr 25, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 25, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Apr 25, 2023

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 05, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Apr 05, 2023

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Apr 05, 2023

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 20, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

REFUSAL PROCESSED BY IB

Feb 14, 2023

REFUSAL PROCESSED BY IB

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 07, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 07, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 07, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY MPU

Jan 25, 2023

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jan 25, 2023

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Nov 24, 2022

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Nov 23, 2022

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Nov 15, 2022

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Jul 09, 2022

APPLICATION FILING RECEIPT MAILED

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Jul 05, 2022

LIMITATION FROM ORIGINAL APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 05, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Jun 30, 2022

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by Circius Pharma AB

Additional USPTO filings from the same owner.

TIN

TINEARITY

79372513

Circius Pharma AB

REGISTERED

EDU

E DUEARITY

79320905

Circius Pharma AB

REGISTERED

OTO

OTOVENT

78823246

CIRCIUS PHARMA AB

REGISTERED

TIN

TINEARITY

79320908

Circius Pharma AB

ABANDONED

Other Marks by Thomas L Ewing

Additional USPTO filings handled by the same attorney of record.

79428601

REGISTERED

INT

INTENSELY DELICIOUS

86418834

REGISTERED

WIM

WIMEA

88208084

REGISTERED

MOB

MOB+

88208087

REGISTERED

OTINOVA

Run a conflict check

Other Marks by Circius Pharma AB

Other Marks by Thomas L Ewing

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company